Testing the neurovascular hypothesis of Alzheimer's disease: LRP-1 antisense reduces blood-brain barrier clearance, increases brain levels of amyloid-beta protein, and impairs cognition.
Saved in:
| Title: | Testing the neurovascular hypothesis of Alzheimer's disease: LRP-1 antisense reduces blood-brain barrier clearance, increases brain levels of amyloid-beta protein, and impairs cognition. |
|---|---|
| Authors: | Jaeger LB (AUTHOR), Dohgu S (AUTHOR), Hwang MC (AUTHOR), Farr SA (AUTHOR), Murphy MP (AUTHOR), Fleegal-DeMotta MA (AUTHOR), Lynch JL (AUTHOR), Robinson SM (AUTHOR), Niehoff ML (AUTHOR), Johnson SN (AUTHOR), Kumar VB (AUTHOR), Banks WA (AUTHOR), Jaeger, Laura B1 (AUTHOR), Dohgu, Shinya (AUTHOR), Hwang, Mark C (AUTHOR), Farr, Susan A (AUTHOR), Murphy, M Paul (AUTHOR), Fleegal-DeMotta, Melissa A (AUTHOR), Lynch, Jessica L (AUTHOR), Robinson, Sandra M (AUTHOR) |
| Source: | Journal of Alzheimer's Disease. 2009, Vol. 17 Issue 3, p553-570. 18p. |
| Database: | Academic Search Ultimate |
| ISSN: | 13872877 |
|---|---|
| DOI: | 10.3233/JAD-2009-1074 |
